Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS (RTALB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.91 +0.06    +0.47%
11:08:26 - Delayed Data. Currency in TRY ( Disclaimer )
  • Volume: 1,146,620
  • Bid/Ask: 12.91 / 12.92
  • Day's Range: 12.80 - 12.97
Type:  Equity
Market:  Türkiye
ISIN:  TRERTAL00018 
RTA 12.91 +0.06 +0.47%

IS:RTALB Financials

 
This summary provides an overview of the most significant critical numbers from each of the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS financial reports, including theRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the IS:RTALB financials over time via breakdowns of their annual reports.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TRY 19.28 million compared to TRY 16.4 million a year ago. Net income was TRY 47.17 million compared to TRY 117.37 million a year ago. Basic earnings per share from continuing operations was TRY 0.472 compared to TRY 1.174 a year ago.For the nine months, sales was TRY 51.47 million compared to TRY 84.94 million a year ago. Net income was TRY 177.94 million compared to TRY 209.62 million a year ago. Basic earnings per share from continuing operations was TRY 1.779 compared to TRY 2.096 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

RTALB Income Statement & Profits

Gross margin TTM 16.58%
Operating margin TTM -31.16%
Net Profit margin TTM 474.59%
Return on Investment TTM -1.85%
 Total Revenue  Net Income
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Revenue 19.28 17.07 15.13 1.08
Gross Profit -1.16 4.03 5.69 0.157
Operating Income -5.38 8.13 -3.23 -15.89
Net Income 47.17 75.9 54.87 71.49

RTALB Balance Sheet

Quick Ratio MRQ 2.09
Current Ratio MRQ 3.05
LT Debt to Equity MRQ 0.44%
Total Debt to Equity MRQ 6.14%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Total Assets 1022.95 832.57 735.08 740.21
Total Liabilities 113.14 121.08 129.96 107.47
Total Equity 909.81 711.49 605.13 632.74

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 0.53
Revenue/Share TTM 0.53
Operating Cash Flow  128.34%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 106.11 -101.71 104.82 -55.92
Cash From Investing Activities -31.21 -3.42 11.41 23.81
Cash From Financing Activities -24.67 -13.23 9.53 0.545
Net Change in Cash 50.23 -118.37 125.76 -31.57
* In Millions of TRY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RTALB Price Commentary

Write your thoughts about RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Hüseyin Solmaz
Hüseyin Solmaz Oct 16, 2020 6:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bio-technology company in Turkey rtalb single market will be valued up to evaluate the novacyt
Super Seka
Super Seka Oct 01, 2020 10:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Really?
Hüseyin Solmaz
Hüseyin Solmaz Sep 22, 2020 8:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sells kits to the world in 25 30 countries
Warren Buffet
Warren Buffet Sep 21, 2020 13:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I will investigate for turkish investor
Hüseyin Solmaz
Hüseyin Solmaz Sep 21, 2020 13:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
search beautiful bright company
YUSUF AKMAN
YUSUF AKMAN Sep 21, 2020 11:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is a great investment opportunity. And it is a little more expensive than free!...
Miktad Amir
Miktad Amir Sep 21, 2020 8:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Best biotechnology company in the world 🇬🇧🇬🇧🇬🇧🇬🇧
Miktad Amir
Miktad Amir Sep 21, 2020 8:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Take this cherry, it won't stay soon 🍒🍒
Seher Düzgün
Seher Düzgün Sep 21, 2020 8:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Weekly seems strong buy. not investment advice
söbeçimen TV KILIÇ
söbeçimen TV KILIÇ Sep 19, 2020 23:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
rtalb=novacty
Fatih Gokcen
Fatih Gokcen Apr 26, 2020 0:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i just wondering. how it seems that stock from there?
kara tekin
kara tekin Apr 26, 2020 0:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Unless you enter the language settings and select Turkish, you cannot follow the comments.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email